Co-Authors
This is a "connection" page, showing publications co-authored by Christos Krogias and Lars Tönges.
Connection Strength
0.814
-
Clinical Profiles and Mortality of COVID-19 Inpatients with Parkinson's Disease in Germany. Mov Disord. 2021 05; 36(5):1049-1057.
Score: 0.236
-
Analysis of nationwide multimodal complex treatment and drug pump therapy in Parkinson's disease in times of COVID-19 pandemic in Germany. Parkinsonism Relat Disord. 2021 04; 85:109-113.
Score: 0.234
-
Letter to the editor: risk comorbidities of COVID-19 in Parkinson's disease patients in Germany. Neurol Res Pract. 2020; 2(1):22.
Score: 0.224
-
Multiple sclerosis is not associated with an increased risk for severe COVID-19: a nationwide retrospective cross-sectional study from Germany. Neurol Res Pract. 2021 Aug 16; 3(1):42.
Score: 0.060
-
The impact of the COVID-19 pandemic on hospitalizations and plasmapheresis therapy in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide analysis from Germany. Ther Adv Neurol Disord. 2021; 14:17562864211030656.
Score: 0.060